Alnylam Prescription drugs’ SWOT evaluation: inventory poised for progress as ATTR-CM drug reveals promise By Investing.com
Alnylam Prescription drugs (NASDAQ:ALNY), a pacesetter in RNA interference (RNAi) therapeutics, has…
Citi maintains Purchase ranking on Alnylam shares with regular value goal By Investing.com
Citi has reaffirmed its Purchase ranking and a $342.00 value goal for…
